New Health Mounjaro UK - From £124.99 | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

New Health Mounjaro UK - From £124.99

Get £20 off your first Mounjaro order at £124.99 with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding New Health Mounjaro: UK Availability, Pricing and Prescription Access

Published: 11 September 2026

New health Mounjaro represents a significant advancement in UK weight loss treatment, offering tirzepatide injections through registered online pharmacy services at competitive pricing from £124.99. As a dual GIP/GLP-1 receptor agonist licensed by the MHRA in 2023, Mounjaro has transformed accessible weight management options for UK patients meeting clinical criteria. This guide explains how new health service models deliver Mounjaro prescriptions, what clinical evidence supports its use, and how Cured Pharmacy's transparent pricing structure compares across the UK market.

What Is New Health Mounjaro and How Does It Work?

New health Mounjaro refers to tirzepatide weight loss injections available through modern UK online pharmacy services that combine clinical expertise with transparent pricing models. Mounjaro works as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, mimicking natural hormones that regulate appetite, food intake, and blood sugar control [1]. This dual mechanism distinguishes Mounjaro from single-action GLP-1 treatments like Wegovy or Saxenda.

Clinical trials demonstrated that Mounjaro users achieved average weight reductions of 15-22.5% of body weight over 72 weeks, depending on the maintenance dose reached [1]. The medication slows gastric emptying, reduces hunger signals, and enhances satiety after meals. UK prescribers assess eligibility based on BMI criteria (typically ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities) and medical history through structured online consultations that meet GPhC standards.

At Cured Pharmacy, new health Mounjaro prescriptions follow a rigorous clinical pathway: patients complete a detailed medical questionnaire reviewed by UK-registered prescribers, receive personalised dosing recommendations, and access ongoing support throughout their treatment journey. All consultations are conducted by GMC-registered doctors or independent prescribers, ensuring compliance with MHRA and NICE guidance on weight management interventions.

New Health Mounjaro Pricing: UK Cost Breakdown and Savings

New health Mounjaro pricing at Cured Pharmacy starts from £124.99 per prescription, representing competitive UK market value for this MHRA-licensed tirzepatide treatment. This transparent pricing model includes the clinical consultation, prescriber review, genuine UK-sourced medication, and discreet home delivery. First-time patients receive £20 off their initial order using code Weightlossnew, reducing the entry cost to £124.99.

The cost structure reflects the medication's dosing schedule: Mounjaro follows a gradual escalation protocol starting at 2.5mg weekly for four weeks, increasing to 5mg, then potentially 7.5mg, 10mg, 12.5mg, or 15mg based on individual response and tolerability [2]. Each pen contains four weekly doses at the prescribed strength. Cured Pharmacy displays all pricing upfront before consultation, eliminating hidden fees common with some UK providers.

Compared to traditional high-street pharmacy models, new health service approaches like Cured Pharmacy reduce overhead costs while maintaining clinical standards through GPhC-registered operations (GPhC 9012511). Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all dispensing protocols, ensuring every Mounjaro prescription meets regulatory requirements. Patients benefit from lower prices without compromising safety or medication authenticity.

Understanding Mounjaro Dosing Costs Over Time

New health Mounjaro treatment costs vary across the escalation schedule. The initial 2.5mg starter dose establishes tolerance before progression to therapeutic levels. Most patients reach maintenance doses between 5mg and 15mg weekly, where sustained weight loss occurs [2]. Cured Pharmacy pricing remains consistent across dose strengths, unlike some providers that increase charges at higher maintenance levels. This predictable cost structure helps patients budget for long-term treatment, which typically spans 6-12 months for optimal results according to clinical trial protocols.

Clinical Evidence Supporting New Health Mounjaro for Weight Loss

New health Mounjaro's efficacy stems from the landmark SURMOUNT clinical trial programme, which enrolled over 5,000 participants across multiple studies [1]. SURMOUNT-1 demonstrated that adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions achieved substantial weight reductions: 15% at 5mg weekly, 19.5% at 10mg weekly, and 22.5% at 15mg weekly over 72 weeks, compared to 2.4% with placebo [1].

These results positioned new health Mounjaro as one of the most effective pharmacological weight loss interventions available in the UK market. Secondary outcomes showed improvements in cardiometabolic markers including HbA1c, blood pressure, lipid profiles, and inflammatory markers [3]. The dual GIP/GLP-1 mechanism appears to produce superior weight loss compared to GLP-1-only treatments, though head-to-head trials continue to refine comparative effectiveness data.

UK regulatory approval followed MHRA review of safety data across 4,887 patient-years of exposure. Common side effects include gastrointestinal symptoms (nausea, diarrhoea, constipation) that typically diminish with continued use and gradual dose escalation [2]. Serious adverse events remained rare, with thyroid C-cell tumour warnings consistent across the GLP-1 medication class. Prescribers at Cured Pharmacy assess contraindications including personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 during consultations.

Real-World Outcomes with New Health Mounjaro

Beyond controlled trials, new health Mounjaro demonstrates effectiveness in real-world UK clinical settings. Post-marketing surveillance data indicates adherence rates exceed 70% at 12 months when patients receive structured support and realistic expectation-setting [4]. Cured Pharmacy's clinical team provides ongoing guidance on managing side effects, optimising injection technique, and integrating dietary modifications that enhance treatment outcomes. This comprehensive approach aligns with NICE recommendations for multicomponent weight management interventions combining pharmacotherapy with lifestyle modification.

Treatment Type Frequency Starting Price
Mounjaro (Tirzepatide) GIP/GLP-1 injection Weekly from £145.00
Wegovy (Semaglutide) GLP-1 injection Weekly from £89.00
Saxenda (Liraglutide) GLP-1 injection Daily from £68.00
Wegovy Oral Tablets GLP-1 oral Daily from £83.00
Orlistat Lipase inhibitor Three times daily from £32.00
Xenical (Orlistat) Lipase inhibitor Three times daily from £49.99

How to Access New Health Mounjaro Through Cured Pharmacy

Accessing new health Mounjaro begins with Cured Pharmacy's streamlined online consultation process, designed to meet GPhC standards while respecting patient time. The medical questionnaire takes under three minutes to complete and covers essential health history: current medications, previous weight loss attempts, cardiovascular health, kidney and liver function, and contraindications specific to GLP-1/GIP therapies.

UK-registered prescribers review each consultation individually, typically within 24 hours on working days. If Mounjaro is deemed clinically appropriate, the prescription is issued electronically to Cured Pharmacy's dispensary. Genuine UK-licensed Mounjaro KwikPens are then prepared for dispatch in discreet, unmarked packaging with temperature-controlled shipping to maintain medication integrity. Patients receive injection technique guidance, storage instructions (refrigerate at 2-8°C), and access to ongoing clinical support via phone ((+44) 116 4646009) or secure messaging.

New health Mounjaro prescriptions require ongoing monitoring. Cured Pharmacy's follow-up protocols include weight tracking, side effect assessment, and dose adjustment recommendations aligned with the licensed escalation schedule. Patients who do not achieve adequate response (defined as <5% weight loss after 16 weeks at therapeutic doses) are reviewed for treatment continuation per NICE guidance [3]. This evidence-based approach ensures resources are directed toward those most likely to benefit from continued therapy.

New Health Mounjaro Compared to Other UK Weight Loss Treatments

New health Mounjaro occupies a distinct position among UK weight loss medications due to its dual receptor mechanism and superior efficacy data. Compared to Wegovy (semaglutide 2.4mg weekly), Mounjaro's highest doses produced approximately 3-5 percentage points greater weight loss in indirect comparisons, though direct head-to-head trials are ongoing [1]. Both medications require weekly subcutaneous injection and follow similar escalation protocols to minimise gastrointestinal side effects.

Saxenda (liraglutide 3mg daily) represents an earlier-generation GLP-1 therapy requiring daily injections and producing average weight loss of 8-9% in clinical trials—effective but less substantial than newer options [4]. Oral treatments like Orlistat work through a different mechanism (lipase inhibition) and produce more modest weight reductions averaging 3-5%, with gastrointestinal side effects related to fat malabsorption rather than appetite suppression.

The choice between new health Mounjaro and alternatives depends on individual factors: injection frequency preference (weekly vs daily), cost considerations, side effect tolerance, and degree of weight loss required to achieve health goals. Cured Pharmacy's prescribers discuss these options during consultations, ensuring patients understand the evidence base supporting each treatment. For many UK patients seeking maximum weight loss efficacy, Mounjaro represents the current evidence-based first choice, subject to prescriber assessment and eligibility criteria.

Switching to New Health Mounjaro from Other Treatments

Patients currently using Wegovy, Saxenda, or other weight loss medications may consider transitioning to new health Mounjaro if seeking enhanced efficacy or different dosing schedules. Switching protocols typically involve discontinuing the current medication and initiating Mounjaro at the standard 2.5mg starter dose, regardless of previous GLP-1 exposure [2]. Cured Pharmacy's prescribers evaluate switching rationale during consultations, considering factors like previous treatment response, tolerability, and clinical goals. Cross-tolerance to gastrointestinal side effects may occur, but individual responses vary, making the gradual escalation protocol essential even for experienced GLP-1 users.

Safety Considerations for New Health Mounjaro in UK Practice

New health Mounjaro safety profiles reflect extensive clinical trial data and post-marketing surveillance coordinated by the MHRA. The most common adverse effects are gastrointestinal: nausea (reported by 20-30% of users), diarrhoea, constipation, and vomiting, typically occurring during dose escalation phases and diminishing over 4-8 weeks [2]. These effects are managed through gradual titration, dietary modifications (smaller meals, reduced fat intake), and symptomatic treatments when necessary.

Serious but rare risks include pancreatitis (0.2-0.4% incidence), gallbladder disease, and hypoglycaemia when combined with insulin or sulfonylureas [3]. The medication carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though human relevance remains uncertain. Absolute contraindications include personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Cured Pharmacy's prescribers screen for these conditions during every consultation.

Kidney function monitoring is recommended for patients with pre-existing renal impairment, as severe gastrointestinal side effects may lead to dehydration and acute kidney injury in susceptible individuals. Pregnant or breastfeeding women cannot use Mounjaro due to insufficient safety data. Women of childbearing potential should use effective contraception and discontinue treatment at least two months before planned conception [2]. These safety protocols ensure new health Mounjaro prescribing at Cured Pharmacy aligns with MHRA licensing conditions and professional practice standards overseen by superintendent pharmacist Tarun Kumar.

Recognising and Managing New Health Mounjaro Side Effects

Effective side effect management enhances new health Mounjaro adherence and treatment success. For nausea, patients are advised to eat smaller, more frequent meals, avoid high-fat foods, and stay well-hydrated. Ginger supplements or antiemetics may provide symptomatic relief in consultation with prescribers. Injection site reactions (redness, itching) affect fewer than 5% of users and typically resolve with site rotation (abdomen, thigh, upper arm). Cured Pharmacy provides detailed injection technique resources and troubleshooting guidance to minimise these issues. Patients experiencing severe abdominal pain, persistent vomiting, or signs of pancreatitis should seek immediate medical attention and discontinue treatment pending clinical review.

Scientific References

  1. Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 11 September 2026]
  2. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines.org.uk. [accessed 11 September 2026]
  3. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating obesity [ID6260]. NICE guidance in development. [accessed 11 September 2026]
  4. Wilding, J. P., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 11 September 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What makes new health Mounjaro different from other weight loss injections?
New health Mounjaro uses a dual GIP/GLP-1 receptor mechanism that produces greater average weight loss (15-22.5%) compared to single-action GLP-1 treatments in clinical trials. It requires only weekly injections and follows a structured dose escalation protocol.
How quickly does new health Mounjaro work for weight loss?
Most patients notice appetite reduction within 1-2 weeks of starting new health Mounjaro, with measurable weight loss typically evident by week 4. Maximum effects occur at therapeutic maintenance doses (10-15mg weekly) after 12-20 weeks of gradual escalation.
Can I buy new health Mounjaro without a prescription in the UK?
No—new health Mounjaro is a prescription-only medication requiring clinical assessment by a UK-registered prescriber. Cured Pharmacy's online consultation ensures safe, legal access through GPhC-registered pharmacy services.
What is the cheapest price for new health Mounjaro in the UK?
Cured Pharmacy offers new health Mounjaro from £124.99 with first-order discount code Weightlossnew (£20 off), representing competitive UK pricing for genuine, MHRA-licensed tirzepatide treatment including clinical consultation and discreet delivery.
How long do I need to take new health Mounjaro?
Typical new health Mounjaro treatment courses last 6-12 months to achieve and consolidate weight loss goals. Long-term maintenance may be appropriate for some patients subject to ongoing prescriber review and response assessment per NICE guidance.
What are the most common new health Mounjaro side effects?
Gastrointestinal effects including nausea (20-30%), diarrhoea, and constipation are most common with new health Mounjaro, typically occurring during dose escalation and improving over 4-8 weeks. Gradual titration and dietary adjustments minimise these effects.
Is new health Mounjaro suitable for people with diabetes?
Mounjaro is licensed for type 2 diabetes management at different doses than weight loss indications. UK prescribers assess suitability for diabetic patients seeking weight loss, considering current medications, HbA1c levels, and hypoglycaemia risk during consultations.
Can I switch to new health Mounjaro from Wegovy or Saxenda?
Yes—patients can transition to new health Mounjaro from other GLP-1 treatments under prescriber guidance. Switching protocols involve discontinuing the current medication and starting Mounjaro at the 2.5mg dose, regardless of previous GLP-1 exposure.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 11 September 2026

Last updated on 11 September 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 11 September 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (11 September 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.